Introduction:
As per the comprehensive report by TechSci Research, “Global RNA Analysis Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028,” the Global RNA Analysis Market exhibited a substantial valuation of USD 8.30 billion in the year 2022. This market is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of 9.60% through the forecast period concluding in 2028. This surge can be attributed to strategic collaborations and partnerships among industry leaders, embracing a diverse approach to amalgamate individual expertise and bolster their market positioning.
RNA Therapeutics Driving Demand:
A significant driver of demand within the Global RNA Analysis Market is the emergence of RNA therapeutics. RNA-based therapies have gained substantial momentum as a promising approach to treat a spectrum of diseases, including genetic disorders, cancer, infectious diseases, and rare conditions. RNA analysis techniques, such as RNA sequencing (RNA-Seq) and quantitative PCR (qPCR), play an indispensable role in the discovery and development of RNA-based therapeutics. These techniques enable researchers to identify therapeutic targets, evaluate gene expression changes in disease states, and validate the efficacy of RNA-based drugs. The rapid development and approval of mRNA vaccines, exemplified by COVID-19 vaccines, underscore the potential of mRNA-based therapeutics, and RNA analysis is pivotal in vaccine development, including assessing mRNA stability, expression levels, and immune responses. Furthermore, RNA analysis identifies disease-associated RNA molecules, including non-coding RNAs (e.g., microRNAs and long non-coding RNAs) and dysregulated protein-coding RNAs, which serve as vital therapeutic targets. The validation of these targets is a fundamental prerequisite for drug development. Additionally, RNA analysis aids in the discovery of RNA biomarkers that can predict disease progression, treatment responses, and patient outcomes, offering crucial support for patient stratification and personalized medicine.
Browse over XX market data Figures and spread through 110 Pages and an in-depth TOC on “ Global RNA Analysis Market.” – https://www.techsciresearch.com/report/rna-analysis-market/18706.html
Impact of COVID-19 Pandemic: The onset of the COVID-19 pandemic had a profound impact on the RNA Analysis Market. Given the severity of the disease caused by the SARS-CoV-2 virus, the pandemic heightened the urgency for testing and diagnosis. Consequently, research efforts to comprehend the genetics of the virus expanded significantly, with the aim of developing effective vaccines. In May 2023, Twist Bioscience Corporation, renowned for providing high-quality synthetic DNA through its silicon platform, introduced a portfolio of RNA sequencing tools, including the Twist RNA Exome, Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) & Hemoglobin (Globin) Depletion Kit. The company also offers custom target enrichment capabilities for RNA and whole transcriptome sequencing. These tools find application in precision medicine, biomarker discovery, and immuno-oncology research, enabling a comprehensive analysis of the transcriptome. The utilization of Twist target enrichment for RNA, either through the RNA Exome or customized RNA panels, facilitates the enrichment of pertinent transcripts.
Challenges of Standardization and Quality Control:
The Global RNA Analysis Market faces considerable challenges in terms of standardization and quality control. Ensuring the accuracy, reproducibility, and comparability of RNA analysis data across different laboratories and experiments is pivotal for achieving meaningful scientific and clinical outcomes. Variability in sample collection, preservation, and handling procedures can significantly impact RNA quality and integrity. To minimize pre-analytical variability, standardized protocols and best practices are indispensable. The choice of RNA extraction method and kit can affect RNA yield and quality; hence, standardized extraction protocols and quality control measures are paramount to ensure consistent results. The availability of well-characterized reference materials, such as RNA standards, assists in standardization by serving as controls for quality assessment and assay performance. Library preparation protocols may introduce biases and variability in RNA-Seq data; thus, standardized library preparation methods and quality control steps, including adapter trimming and size selection, are pivotal in mitigating these challenges.
Growing Demand for Reagents and Consumables:
The reagents and consumables segment within the RNA Analysis Market offers ready-to-use products that streamline RNA analysis procedures and research. The segment is anticipated to witness growth during the forecast period, driven by the increased prevalence of infectious diseases and oncological occurrences. Furthermore, the demand for high-quality reagents is on the rise, as evidenced by their extensive utilization in transcriptome investigations. The growth of the reagents/consumables segment is further bolstered by the biotechnological industry’s intensified R&D efforts, increased government funding for life science research, and a surge in research encompassing integrated omics studies.
Cancer and Infectious Diseases:
According to the February 2022 update by the World Health Organization (WHO), cancer stands as a leading cause of mortality worldwide, with cancer-causing infections such as human papillomavirus (HPV) and hepatitis being responsible for approximately 30% of cancer cases in low- and lower-middle-income countries. As a result of the high disease burden posed by cancer and infectious diseases, there is a growing demand for diagnosis in medical specialties and diagnostic care centers, which is expected to drive the growth of this segment during the forecast period.
Product Launches Driving Growth:
The introduction of products by market players has further accelerated the growth of the RNA Analysis Market segment. For instance, in March 2021, PCR Biosystems, a United Kingdom-based specialist in DNA and RNA analysis, launched a range of Iso Fast BST Polymerase reagents for rapid, robust, and sensitive RNA amplification. Such product approvals are expected to fuel significant growth within the segment during the analysis period.
Beneficiaries of This Report:
This report holds invaluable insights for a diverse range of stakeholders:
- Pharmaceutical Companies: Seeking to explore evolving market dynamics, technological innovation potential, and competitive landscapes.
- Healthcare Providers: Looking for in-depth knowledge on advanced treatments and strategies for patient management.
- Investors: Eager to identify growth prospects and investment opportunities within the RNA Analysis Market.
- Patient Advocacy Groups: Aiming to stay informed about the latest advancements and therapy options.
- Regulatory Bodies: Interested in tracking the approval and regulation of RNA-based therapies for various diseases.
- Academic and Research Institutions: Exploring opportunities for collaboration and further advancements in RNA analysis.
- Biotechnology Companies: Seeking to understand market trends and demand for reagents and consumables in RNA analysis.
Some of the major companies operating in the Global RNA Analysis Market include:
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Pacific Bioscience of California, Inc.
- Affymetrix, Inc.
Customers can also request for 10% free customization on this report.
“Certain areas, particularly in North America, are projected to exert significant demand for RNA analysis. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global RNA Analysis Market in the forecast period,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.
RNA Analysis Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Kits & Reagents, Services, Instruments), By Technology (Real Time-PCR (qPCR), Microarray, Sequencing, others), By Application (Epigenetics, Infectious Diseases & Pathogenesis, Alternative RNA Splicing, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics), By End-use (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, others), by region, and Competition evaluated the future growth potential of Global RNA Analysis Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global RNA Analysis Market
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=18706
Recently Published Reports –
Artificial Intelligence in Diabetes Management Market
Contact Techsci Research-
US –
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Germany –
S-01, 2.floor, Subbelrather Straße,
15a Cologne,
Germany 50823
Tel: +49 221 65058833
Email: [email protected]